Virtu Financial LLC Exagen Inc. Transaction History

Virtu Financial LLC

$1.96 Billion
Q2 2025

A detailed history of Virtu Financial LLC transactions in Exagen Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 10,039 shares of XGN stock, worth $95,972. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,039

Holding current value

$95,972

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 12, 2025	BUY	$3.93 - $7.71 $39,453 - $77,400	10,039 New	10,039 $70,000
Q4 2024 Feb 11, 2025	BUY	$2.43 - $6.0 $27,223 - $67,218	11,203 New	11,203 $46,000

Others Institutions Holding XGN

# of Institutions

Shares Held

9.08M

Call Options Held

Put Options Held

Rtw Investments, LP New York, NY

1.7M
Shares

$16.2 Million
0.18% of portfolio
Toronto Dominion Bank Toronto, Ontario, A6

851K
Shares

$8.14 Million
0.01% of portfolio
Balyasny Asset Management LLC Chicago, IL

719K
Shares

$6.87 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

682K
Shares

$6.52 Million
0.0% of portfolio
Silvercrest Asset Management Group LLC New York, NY

532K
Shares

$5.08 Million
0.03% of portfolio

View Full List

About EXAGEN INC.

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $155M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

More about XGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account